Airway Pressure Release Ventilation (APRV) Protocol Early Used in Acute Respiratory Distress Syndrome
Launched by WEST CHINA HOSPITAL · Dec 21, 2015
Trial Information
Current as of August 11, 2025
Unknown status
Keywords
ClinConnect Summary
Although mechanical ventilation is life-sustaining for patients with ARDS, it can perpetuate lung injury. A number of recent advances have greatly improved in the mechanical ventilation strategies and treatment for acute respiratory distress syndrome (ARDS), however, Mortality remains high, even with the use of low tidal volume and adequate positive end expiratory pressure(PEEP). Numerous experimental showed that the BILEVEL-APRV mode used in animal ARDS model can improve gas exchanges and hemodynamic tolerance of the ventilation while reducing the dosage for sedative drugs.
The aim of thi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Acute respiratory distress syndrome,according to the Berlin definition of ARDS, - The receipt of endotracheal mechanical ventilation for a period was no longer than 48 hours
- • A ratio of the partial pressure of arterial oxygen (PaO2) to the fraction of inspired oxygen(FiO2) was less than 250.
- Exclusion Criteria:
- • Pregnancy
- • The expected duration of mechanical ventilation was less than 48 hours
- • Intracranial hypertension (suspected or confirmed)
- • Neuromuscular disorders that are known to prolong the need for mechanical ventilation
- • Known or suspected chronic obstructive pulmonary disease(COPD)
- • Preexisting conditions with an expected 6-month mortality exceeding 50%
- • Pneumothorax (drained or not)at enrollment
- • Treatment with extracorporeal support (ECMO) at enrollment
- • There was a lack of commitment to life support.
About West China Hospital
West China Hospital, affiliated with Sichuan University, is a leading medical institution renowned for its comprehensive healthcare services, advanced research initiatives, and commitment to medical education. As a prominent clinical trial sponsor, the hospital leverages its extensive resources and expertise to facilitate innovative research in various therapeutic areas. With a focus on improving patient outcomes and advancing medical knowledge, West China Hospital collaborates with various stakeholders to conduct rigorous clinical trials that adhere to the highest ethical and scientific standards. Its state-of-the-art facilities and multidisciplinary teams ensure the successful execution of trials, contributing significantly to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chengdu, Sichuan, China
Patients applied
Trial Officials
Yan Kang, doctor
Study Director
West China Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials